Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 11:18:1457527.
doi: 10.3389/fnhum.2024.1457527. eCollection 2024.

The effectiveness of olfactory training for chronic olfactory disorder following COVID-19: a systematic review

Natalia Treder-Rochna  1 , Aleksandra Mańkowska  1 , Wiktoria Kujawa  1 , Michał Harciarek  1
Affiliations

The effectiveness of olfactory training for chronic olfactory disorder following COVID-19: a systematic review

Natalia Treder-Rochna et al. Front Hum Neurosci. .

Abstract

Background: Chronic olfactory disorders are some of the most frequent post-COVID-19 presentations. Olfactory training (OT) is currently the most popular method used for treating post-viral olfactory dysfunction (PVOD). We evaluated the effect of olfactory training on the chronic olfactory disorders of patients infected with COVID-19.

Methodology: A systematic literature search was performed per PRISMA guidelines in PubMed, Scopus, Web of Science, EBSCOhost, and the Cochrane Library. Only patients with chronic olfactory disorders of 30 days or more were included. The primary outcome was the olfactory score at the end of follow-up. In all studies, improvement was defined as a positive change over time in the results of objective psychophysical olfactory tests. The most commonly used test was the Sniffin' Sticks. Typically, outcome measures involved comparing the mean olfactory scores. In the Sniffin' Sticks test, an improvement was also indicated by a change of 5.5 points or more in the Threshold, Discrimination, and Identification scores.

Results: Fourteen studies (1.596 participants) were included in this review. Among the included studies, up to 10 were RCTs. Nine studies assessed the combined effects of adjuvant therapy and olfactory training, while five studies assessed only OT.

Conclusions: In our assessment, olfactory training alone produces significant improvements in chronic olfactory dysfunctions. However, a combined therapy approach is essential to achieve more effective outcomes. Integrating olfactory training with adjuvants like CoUltraPEALut, Cerebrolysin, and oral Vitamin A has demonstrated substantial benefits in enhancing post-COVID-19 olfactory function. Strict adherence to the OT protocol and extending the duration of OT to 3 months or more significantly enhance treatment outcomes.

Keywords: COVID-19; adjuvants; chronic olfactory disorder; olfactory training; smell.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
PRISMA diagram.
See this image and copyright information in PMC

References

    1. Asvapoositkul V., Samuthpongtorn J., Aeumjaturapat S., Snidvongs K., Chusakul S., Seresirikachorn K., et al. . (2023). Therapeutic options of post-COVID-19 related olfactory dysfunction: a systematic review and meta-analysis. Rhinology 61, 2–11. 10.4193/Rhin22.221 - DOI - PubMed
    1. Bérubé S., Demers C., Bussière N., Cloutier F., Pek V., Chen A., et al. . (2023). Olfactory training impacts olfactory dysfunction induced by COVID-19: a pilot study. ORL J. Otorhinolaryngol. Relat. Spec. 85, 57–66. 10.1159/000528188 - DOI - PMC - PubMed
    1. Boscolo-Rizzo P., Hummel T., Hopkins C., Dibattista M., Menini A., Spinato G., et al. . (2021). High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: a matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation. Rhinology 59, 517–527. 10.4193/Rhin21.249 - DOI - PubMed
    1. Brainin M. (2018). Cerebrolysin: a multi-target drug for recovery after stroke. Expert Rev. Neurother. 18, 681–687. 10.1080/14737175.2018.1500459 - DOI - PubMed
    1. Cain W. S., Gent J. F., Goodspeed R. B., Leonard G. (1988). Evaluation of olfactory dysfunction in the Connecticut Chemosensory Clinical Research Center. Laryngoscope 98, 83–88. 10.1288/00005537-198801000-00017 - DOI - PubMed

Publication types

LinkOut - more resources